LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice.
Hong-Xia MeiYang YeHao-Ran XuShu-Yang XiangQian YangHong-Yu MaSheng-Wei JinQian WangPublished in: Journal of inflammation research (2021)
These results suggest that LXA4 may be a promising therapy for preventing and treating ARDS.